In this study, we investigated the relationship between the soluble form of CD80 (sCD80) which is a ligand for the inhibitory system CTLA-4, in blood, and clinicopathological parameters in patients with soft tissue tumors.<h4>Methods</h4>A total of 119 patients with primary soft tissue tumors were enrolled in this study. The gene discussed is CD80; the disease is soft tissue neoplasm.